Richard J. Lucariello

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/cffeeb40-490c-11ef-963b-93be6336365a.jpg

First Name

Richard

Last Name

Lucariello

NPI

1396763926

Faculty ID

14019

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

<p>Clinic Cardiology, Echocardiography and Nuclear Cardiology</p>

Research Focus

<p>Dr. Lucariello is a member of the Montefiore Einstein Center for Heart &amp;Vascular Care Research Board.</p>

Elsevier Profile

EMR ID

4987

Biography

<p>Richard Lucariello, MD, is Clinical Director, Non-Invasive Cardiology at the Wakefield Campus of Montefiore and Assistant Professor of Clinical Medicine at our Albert Einstein College of Medicine. His clinical interests include clinical cardiology, echocardiography and nuclear cardiology.</p><p>Dr. Lucariello earned his Bachelor of Science in biology at Fordham University in 1979, followed by his Doctor of Medicine at New York Medical College in 1984. He began his postdoctoral training at Westchester County Medical Center, completing a medicine internship in 1985 and a two-year medicine residency in 1987. He then completed a cardiology fellowship at St. Vincent&rsquo;s Hospital &amp; Medical Center in 1989 before returning to Westchester County Medical Center to complete a nuclear cardiology fellowship in 1990.</p><p>Following his clinical interests, Dr. Lucariello&rsquo;s research focuses primarily on echocardiography. His work has been published in peer-reviewed journals and abstracts.</p><p>Dr. Lucariello is actively involved in educating medical residents and cardiology fellows at the Wakefield campus, and was awarded the Program Director&rsquo;s Training Award for Cardiology for the 2011&ndash;2012 academic year. He is board certified and is a member of several professional organizations, including the American College of Cardiology, the American Society of Nuclear Cardiology and the American Society of Echocardiography.</p>

Is Open Scheduling

Off

Ross I. Kaye

https://assets.montefioreeinstein.org/profiles/images/default-profile-blue.svg

First Name

Ross

Last Name

Kaye

NPI

1568737831

Faculty ID

18024

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

78694

Is Open Scheduling

Off

Tannaz Iranpour Boroujeni

https://assets.montefioreeinstein.org/profiles/images/default-profile-blue.svg

First Name

Tannaz

Last Name

Iranpour Boroujeni

NPI

1003175597

Faculty ID

14384

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

54424

Is Open Scheduling

Off

Joseph J. Hong

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/bb016ac0-7e92-11ec-8207-c982689cc96c.jpg

First Name

Joseph

Last Name

Hong

NPI

1821437815

Faculty ID

16999

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

56395

Is Open Scheduling

Off

Sheryl R. Haut

https://assets.montefioreeinstein.org/profiles/images/physphoto/Haut_Sheryl_MD_420x504.jpg

First Name

Sheryl

Last Name

Haut

NPI

1679658991

Faculty ID

5312

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Dr. Sheryl Haut is Director of the Adult Epilepsy Program and Chief of Service, Neurology at Montefiore Einstein. She is the previous Chair of the North American Commission of the International League Against Epilepsy. Her research interests include: the temporal distribution of seizures, with emphasis on seizure clustering; seizure prediction and pre-emption; and alternative therapies for epilepsy. She is currently conducting electronic diary studies of seizure prediction and was the Principal Investigator of the first randomized controlled trial of stress management for refractory epilepsy using smartphone diaries. Dr. Haut has a Masters in Clinical Research Methods, and completed a K23 career development award from the NIH. She maintains an active adult epilepsy practice at Montefiore Medical Center, Moses Division.</p>

Research Areas

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Dr. Haut focuses on the special needs of epilepsy patients, such as pregnancy, stress, driving, work-related issues and issues in the elderly.

Research Focus

Dr. Haut's research is focused on seizure clustering; seizure prediction and pre-emption; and alternative therapies for epilepsy.

Elsevier Profile

Selected Publications

<ol>
<li>
<p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; margin-left: .25in; text-indent: -.25in; mso-pagination: widow-orphan; mso-list: l0 level1 lfo1; tab-stops: list .25in;"><!-- [if !supportLists]--><span style="mso-bidi-font-size: 12.0pt; border: none windowtext 1.0pt; mso-border-alt: none windowtext 0in; padding: 0in;">Correa DJ, Labovitz DL, Milstein MJ, Monderer R, Haut SR. <strong><span style="font-weight: normal; mso-bidi-font-weight: bold;">Folding a neuroscience </span></strong></span><strong style="text-indent: -0.25in;"><span style="font-weight: normal; mso-bidi-font-weight: bold;">center into streamlined Covid-19 response teams: Lessons in origami. Neurology 2020, in press.</span></strong></p>
</li>
<li>
<p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; margin-left: .25in; text-indent: -.25in; mso-pagination: widow-orphan; mso-list: l0 level1 lfo1; tab-stops: list .25in;"><span lang="EN" style="text-indent: -0.25in;"><span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';">&nbsp;</span></span><span class="author" style="text-indent: -0.25in;"><span lang="EN">Galanopoulou, AS</span></span><span lang="EN" style="text-indent: -0.25in;">, <span class="author">Ferastraoaru, V</span>, <span class="author">Correa, DJ</span>, </span><span lang="EN" style="text-indent: -0.25in;">Cherian K, Duberstein S, Gursky J, Hanumanthu R, Hung C, Molinero I, Khodakivska O, Legatt AD, Patel P, Rosengard J, Rubens E, Sugrue W, Yozawitz E, Mehler M, Ballaban-Gil K, Haut SR, Mosh&eacute; SL, Boro A. </span><span lang="EN" style="text-indent: -0.25in;">&nbsp;<span class="articletitle">EEG findings in acutely ill patients investigated for SARS</span></span><span class="articletitle" style="text-indent: -0.25in;"><span lang="EN" style="mso-bidi-font-size: 12.0pt; font-family: 'Cambria Math','serif'; mso-bidi-font-family: 'Cambria Math'; mso-ansi-language: EN;">‐</span></span><span class="articletitle" style="text-indent: -0.25in;"><span lang="EN">CoV-2/COVID</span></span><span class="articletitle" style="text-indent: -0.25in;"><span lang="EN" style="mso-bidi-font-size: 12.0pt; font-family: 'Cambria Math','serif'; mso-bidi-font-family: 'Cambria Math'; mso-ansi-language: EN;">‐</span></span><span class="articletitle" style="text-indent: -0.25in;"><span lang="EN">19: A small case series preliminary report</span></span><span lang="EN" style="text-indent: -0.25in;">. Epilepsia Open. <span class="pubyear">2020</span>; <span class="vol">5</span>: <span class="pagefirst">314</span>&ndash; <span class="pagelast">324</span>.&nbsp;</span></p>
</li>
<li>
<p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; margin-left: .25in; text-indent: -.25in; mso-pagination: widow-orphan; mso-list: l0 level1 lfo1; tab-stops: list .25in;"><a href="https://www.sciencedirect.com/science/article/pii/S0920121119303869#!">… class="text2"><span style="color: windowtext; text-decoration-line: none;">Chiang S,&nbsp;</span></span></a><a name="baut0015"></a>Haut SR.&nbsp;<a name="baut0020"></a>Ferastaoaru V,&nbsp;<a name="baut0025"></a>Rao VR,&nbsp;<a name="baut0030"></a>&nbsp;M,&nbsp;<a name="baut0035"></a>Theodore WH,&nbsp;<a href="https://www.sciencedirect.com/science/article/pii/S0920121119303869#!">… class="text2"><span style="color: windowtext; text-decoration-line: none;">Moss</span></span></a><a name="baut0040"></a>&nbsp;R,&nbsp;Goldenholz DM.&nbsp;<span class="title-text">Individualizing the definition of seizure clusters based on temporal clustering analysis. Epilepsy Res 2020;163:1-10.</span></p>
</li>
<li>
<p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; margin-left: .25in; text-indent: -.25in; mso-pagination: widow-orphan; mso-list: l0 level1 lfo1; tab-stops: list .25in;"><strong style="text-indent: -0.25in;"><span style="font-weight: normal;"><span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';">&nbsp;</span></span></strong><strong style="text-indent: -0.25in;"><span style="border: none windowtext 1.0pt; mso-border-alt: none windowtext 0in; padding: 0in; font-weight: normal; mso-bidi-font-weight: bold;">Privitera M, Haut SR, Lipton RB, McGinley J, Cornes S. Seizure Self-prediction in a Randomized Controlled Trial of Stress Management. Neurology 2019;93(22):e2021-e2031</span></strong><span style="text-indent: -0.25in; color: windowtext;">1.<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>
</li>
<li>
<p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; margin-left: .25in; text-indent: -.25in; mso-pagination: widow-orphan; mso-list: l0 level1 lfo1; tab-stops: list .25in;"><span lang="EN" style="text-indent: -0.25in; color: windowtext;">Ferastraoaru V, Goldenholz DM, Chiang S, Moss R, Theodore WH, Haut SR. Characteristics of large patient-reported outcomes: Where can one million seizures get us? Epilepsia Open. 2018 Jul 4;3(3):364-373&nbsp;</span></p>
</li>
<li>
<p class="MsoNormal" style="margin-left: 0.25in; text-indent: -0.25in; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">&nbsp;</p>
</li>
<li>
<p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; margin-left: .25in; text-indent: -.25in; mso-pagination: widow-orphan; mso-list: l0 level1 lfo1; tab-stops: list .25in;"><span style="text-indent: -0.25in; font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';">&nbsp; </span><span lang="EN" style="text-indent: -0.25in;">Goldenholz DM, Goldenholz SR, Moss R, French J, Lowenstein D, Kuzniecky R, Haut S, Cristofaro S, Detyniecki K, Hixson J, Karoly P, Cook M, Strashny A, Theodore WH. Is seizure frequency variance a predictable quantity? Ann Clin Transl Neurol. 2018 Jan 9;5(2):201-207</span></p>
</li>
<li>
<p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; margin-left: .25in; text-indent: -.25in; mso-pagination: widow-orphan; mso-list: l0 level1 lfo1; tab-stops: list .25in;"><span style="text-indent: -0.25in; font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';">&nbsp; </span><span style="text-indent: -0.25in;">Haut SR, Lipton RB, Cornes S, Dwivedi AK, Wasson R, Cotton S, Strawn J, Privitera M. Behavioral interventions as a treatment for epilepsy: A multicenter randomized controlled trial. &nbsp;</span><span class="jrnl" style="text-indent: -0.25in;">Neurology</span><span style="text-indent: -0.25in; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">. 2018 Mar 13;90(11)</span></p>
<p style="margin-left: .25in; text-indent: -.25in; line-height: normal; mso-list: l0 level1 lfo1; tab-stops: list .25in;">&nbsp;</p>
<p class="MsoNormal" style="margin-left: 0.25in; text-indent: -0.25in; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">&nbsp;</p>
</li>
<li>Fisher RS, Cross JH, D&rsquo;Souza C, French JA, Haut SR, Higurashi N, Hirsch E, Jansen FE, Lagae L, Moshe SL, Peltola J, Roulet Perez E, Scheffer IE, Schulze-Bonhage A, Somerville E, Sperling M, Yacubian E, Zuberi SM. Instruction manual for the ILAE 2017 operational classification of seizure types. Epilepsia. 2017 Apr;58(4):531-542</li>
<li>Patel P, Ferastaoaru V, Gold D, Lipnick A, Jehle R, Haut SR. Clinical characterization of the pre-ictal state in the pediatric population: A caretaker&rsquo;s perspective. Epilepsy Behav. 2017 Apr 18;70(Pt A):193-197</li>
<li>Robbins MS, Haut SR, Lipton RB, Milstein MJ, Ocava LC, Ballaban-Gil K, Mosh&eacute; SL, Mehler MF. A dedicated scholarly research program in an adult and pediatric neurology residency program. Neurology. 2017 Apr 4;88(14):1366-1370</li>
<li>Haut SR, Seinfeld S, Pellock J. Benzodiazepine use in Seizure emergencies: A systematic review. Epilepsy Behav. 2016 Oct;63:109-117.</li>
<li>Ferastraoaru V, Schulze-Bonhage A, Lipton RB, D&uuml;mpelmann M, Legatt AD, Blumberg J,&nbsp; Haut SR. Termination of seizure clusters is related to the duration of focal seizures. Epilepsia &nbsp;2016 Mar 31.</li>
<li>Pillai J, Haut SR, Masur D. Orbitofrontal cortex dysfunction in Psychogenic Non-Epileptic Seizures. A proposal for a two-factor model. Med Hypotheses. 2015 Apr;84(4):363-9</li>
<li>Haut SR. Seizure Clusters: Characteristics and Treatment. Curr Opin Neurol. 2015 Apr;28(2):143-50</li>
<li>Lipton RB,BuseDC, Hall CB, Tennen H, DeFreitas TA, Borkowski TM, Haut SR. Reduction in Perceived Stress as a Migraine Trigger: Testing the &ldquo;Let-down Headache&rdquo; Hypothesis. Neurology 2014; Apr 22;82(16):1395-401</li>
<li>Privitera M, Walters M, Lee I, Polak E, Fleck A, Schwieterman D, Haut SR. Characteristics of People with Stress Precipitated Seizures. Epilepsy Behav 2014 Oct;41:74-77</li>
<li>Haut SR, Hall CB, Borkowski T, Tennen H, Lipton RB. Modeling seizure self-prediction: An e-diary study. Epilepsia 2013; Nov;54(11):1960-7.</li>
<li>Haut SR. Predicting seizures: Are we there yet? Epilepsy Currents 2013 Nov;13(6):276-8.</li>
<li>Haut SR, Hall CB, Borkowski T, Tennen H, Lipton RB. Clinical features of the pre-ictal state: Mood changes and premonitory symptoms. Epilepsy and Behavior 2012, 23:415-421.</li>
<li>Pillai J, Haut SR. Patients with epilepsy and psychogenic non-epileptic seizures: An inpatient video-EEG monitoring study. Seizure. 2012, 21(1):24-7.</li>
<li>Schulze-BonhageA, Haut SR. Premonitory features and seizure self-prediction: Artifact or real? Epilepsy Res 2011, 97(3);231-235.</li>
<li>Haut SR, Lipton RBL. Predicting Seizures: A Behavioral Approach. Neurol Clinics 2009, 27(4);925-940.</li>
<li>Haut SR. Psychiatric History and Temporal Lobectomy Outcome: Looking to the Past to Predict the Future. Epilepsy Currents 2009, 9(5):1-3</li>
<li>Haut SR, Katz M, Masur J, Lipton RBL. Seizures in the Elderly: Impact on Mental Status, Mood and Sleep. Epilepsy and Behavior 2009;14(3):540-544.</li>
<li>Hall CB, Lipton RB, Tennen H, Haut SR. Early Follow-up Data From Seizure Diaries Can Be Used To Predict Subsequent Seizures in Same Cohort By Borrowing Strength Across Participants. Epilepsy and Behavior 2009;14(3);472-475.</li>
<li>Bower CM, Hays RD, Devinsky O, Spencer SS, Sperling MR, Haut S, Vassar S, Vickrey BG. Expectations Prior to Epilepsy Surgery: An Exploratory Comparison of Men and Women. Seizure 2009;18(3):228-231</li>
<li>Brody BD and Haut SR. Ending the Doctor-Patient Relationship in Neurology Practice. The Neurologist 2009;15(5): 277-81.</li>
<li>Haut SR, Hall CD, Masur J, Lipton RB. Seizure Occurrence: Precipitants and Prediction. Neurology 2007;69 1905-1910.</li>
<li>Lado F, Spiegel R, Masur J, Boro A, Haut SR. Value of routine screening for bone demineralization in an urban population of patients with epilepsy. Epil Res 2007; 78(2-3);155-160</li>
<li>Chin PS, Berg AT, Spencer SS, Sperling MR, Haut S et al. Employment Outcomes Following Resective Epilepsy Surgery. Epilepsia 2007;Dec;48(12):2253-7.8.<span style="font-family: 'Times New Roman'; font-weight: normal; font-style: normal; font-size: 7.0pt; line-height: normal; font-variant: normal;">&nbsp; &nbsp;</span></li>
<li>Haut SR, Hall CD, LeValley A, Lipton RB. Can patients with epilepsy predict their seizures? Neurology, 2007; 68:262-266.</li>
<li>Spencer SS, Berg AT, Vickrey BG, Sperling MR, Bazil CW, Haut S, Langfitt JT, Walczak TS, Devinsky O; Multicenter Study of Epilepsy Surgery. Health-related quality of life over time since resective epilepsy surgery. Ann Neurol. 2007 Oct;62(4):327-34</li>
<li>Haut SR, Bigal M, Lipton RB. Chronic Disorders With Episodic Manifestations: Focus on Epilepsy and Migraine. Lancet Neurology 2006;5:148-157.&nbsp;</li>
</ol>

EMR ID

3969

Biography

<p>Dr. Sheryl Haut is Director of the Adult Epilepsy Program at Montefiore. She has extensive experience treating all forms of epilepsy in young and older adults, and in tailoring treatments to the individual. She focuses on special needs such as pregnancy, stress, driving, work related issues, and issues in the elderly.</p> <p>Dr. Haut has an extensive research background, including a Masters of Clinical Research with Distinction from Albert Einstein College of Medicine. Her research interests focus on seizure clustering; seizure prediction and pre-emption; and alternative therapies for epilepsy. She is one of the first investigators to run a clinical trial of stress management for epilepsy, using smartphone diaries.</p> <p>Dr. Haut is the current Chair of the North American Commission of the International League Against Epilepsy, and is active nationally in the American Epilepsy Society, and the American Academy of Neurology, serving on committees of both organizations. She has authored more than 50 papers/book chapters on epilepsy, and has been featured in Top Doctors of NY annually since 2009. She maintains an active adult epilepsy practice at the Moses Campus.</p>

Is Open Scheduling

Off

Valentyna Goloborodko

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/061db580-470d-11ec-9350-298b34a4a389.jpg

First Name

Valentyna

Last Name

Goloborodko

NPI

1194010728

Faculty ID

13925

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

5492

Is Open Scheduling

Off

David L. Goldman

https://assets.montefioreeinstein.org/profiles/images/Goldman_David_MD_2x.jpg

First Name

David

Last Name

Goldman

NPI

1730245671

Faculty ID

5923

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>The medical community has long recognized fungi as important allergens for patients with asthma. Interestingly, fungal sensitization is more common in children and has been linked to severe asthma resulting in death. The accepted paradigm is that fungal sensitization occurs as a result of recurrent, transient environmental exposures. Yet, increasing evidence suggests that fungi may interact with people in unrecognized ways to promote asthma. My lab is interested in understanding the role of subclinical fungal infections in asthma and their potential contribution to the high prevalence of asthma in urban areas.<br /><br /></p>
<p><em>Cryptococcus neoformans</em> is an encapsulated fungus that is well suited to serve as co-factor in urban asthma. <em>C. neoformans</em> colonizes pigeon droppings and is endemic to urban areas. Once inhaled, this fungus causes persistent, subclinical infections. We have demonstrated that the majority of Bronx children older than 2 years have serologic evidence of cryptococcal infection. Cryptococcal infection induces TH2 inflammation in animal models. In a rat model, we have shown that cryptococcal pulmonary infection acts a co-factor to enhance allergic inflammation to allergen challenge and promotes airway hyper-responsiveness, both hallmark features of asthma. Pulmonary cryptococcosis also induces chitinase expression, which has recently been implicated as an essential mediator of allergic inflammation.<br /><br /></p>
<p>To study this phenomenon, we have established collaborations with Pulmonary Medicine, Critical Care and Emergency Medicine at the Children&Atilde;&cent;&acirc;&sbquo;&not;&acirc;&bdquo;&cent;s Hospital of Montefiore. These collaborations provide access to the large number of children with asthma in the Bronx. Current studies underway include a characterization of chitinase expression among asthmatics and a comparison of cryptococcal infection prevalence among asthmatics and non-asthmatics. Animal experimentation directed at understanding the mechanisms and variables related to fungal induced asthma are also underway.<br /><br /></p>
<p>In addition to fungal studies, my lab is interested in anthrax pathogenesis. <em>Bacillus anthracis</em> is widely recognized as a potential agent of bioterrorism as evidenced by the 2001 anthrax attack. The toxins of <em>B. anthracis</em> are essential to virulence. In collaborations with Drs. Arturo Casadevall and Jurgen Brojatsch, we have studied the mechanisms by which <em>Bacillus anthracis</em> toxins contribute to host death. We have identified a previously unrecognized protease in human serum that inactivates the protective antigen component of lethal toxin <em>in vitro</em>. The precise protease and its role in the host response and susceptibility to anthrax remain to be determined. We have also identified a potential role for platelet activating factor (PAF) in mediating the lethal effects of toxin, including the alterations in vascular permeability which is characteristic of anthrax. Together, these observations may have important implications in developing new approaches to the treatment of anthrax.</p>

Research Areas

Research Profile

Clinical Profile

CHAM Provider

On

Professional Title

Clinical Focus

Dr. Goldman has a special interest in fungal infections in children, including hospital and community acquired mycoses.

Research Focus

Dr. Goldman has two primary research interests: the contribution of fungi to the development of asthma in children and the pathogenesis of C. difficile infection in children

Elsevier Profile

Selected Publications

<div id="pmid_19708853" class="rprt">
<div class="rprtNum">&nbsp;</div>
<br />&nbsp;</div>
<p>1.&nbsp; Fungal sensitization in childhood persistent asthma is associated with disease severity.&nbsp; Vicencio AG, Santiago MT, Tsirilakis K, Stone A, Worgall S, Foley EA, Bush D, Goldman DL.&nbsp; Pediatr Pulmonol. 2013 Feb 8. doi: 10.1002/ppul.22779. [Epub ahead of print]</p>
<p>&nbsp;</p>
<p>2.&nbsp; Increased chitinase expression and fungal-specific antibodies in the bronchoalveolar lavage fluid of asthmatic children.&nbsp; Goldman DL, Li X, Tsirilakis K, Andrade C, Casadevall A, Vicencio AG.&nbsp; Clin Exp Allergy. 2012 Apr;42(4):523-30. doi: 10.1111/j.1365-2222.2011.03886.x. Epub 2011 Oct 10.</p>
<p>&nbsp;</p>
<p>3.&nbsp; CHIT1 mutations: genetic risk factor for severe asthma with fungal sensitization?&nbsp; Vicencio AG, Chupp GL, Tsirilakis K, He X, Kessel A, Nandalike K, Veler H, Kipperman S, Young MC, Goldman DL.</p>
<p>Pediatrics. 2010 Oct;126(4):e982-5. doi: 10.1542/peds.2010-0321. Epub 2010 Sep 6.</p>
<p>&nbsp;</p>
<p>4.&nbsp; Proteasome inhibitors prevent caspase-1-mediated disease in rodents challenged with anthrax lethal toxin.Muehlbauer SM, Lima H Jr, Goldman DL, Jacobson LS, Rivera J, Goldberg MF, Palladino MA, Casadevall A, Brojatsch J.&nbsp; Am J Pathol. 2010 Aug;177(2):735-43. doi: 10.2353/ajpath.2010.090828. Epub 2010 Jul 1. Erratum in: Am J Pathol. 2010 Oct;177(4):2145.</p>
<p>&nbsp;</p>

EMR ID

4147

Biography

<p>David L. Goldman, MD, is Fellowship Director, Pediatric Infectious Diseases; Associate Professor, Pediatrics, and Associate Professor, Microbiology and Infectious Diseases at Montefiore Einstein. He has a special interest in fungal infections in children, including hospital and community acquired mycoses.</p><p>After earning his Bachelor of Arts from Brandeis University in 1983, Dr. Goldman attended Jefferson Medical College, earning his Doctor of Medicine in 1987. He began his postdoctoral education at St. Vincent&rsquo;s Hospital. Yale University, New York Medical College, completing a yearlong internship before coming to Einstein&rsquo;s Jacobi Medical Center, where he completed a residency in pediatrics in 1991, a fellowship in academic pediatrics in 1992 and a fellowship in pediatric infectious diseases in 1996.</p><p>Dr. Goldman has two primary research interests: the contribution of fungi to the development of asthma in children and the pathogenesis of C. difficile infection in children. He has shared his work through conferences, symposia, books, peer-reviewed journals, review articles, abstracts and poster presentations. He has also been an ad hoc reviewer for several journals including <em>Infection and Immunity, Microbes and Infection</em>, and <em>Medical Mycology</em>.</p><p>Dr. Goldman is board certified in pediatrics and pediatric infectious diseases. He is a member of the American Society of Microbiology, the Infectious Diseases Society of America and the Pediatric Infectious Diseases Society.</p>

Is Open Scheduling

Off

Purnima Garg

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/58355680-88ed-11ec-b5d6-3f90a6bc79f5.jpeg

First Name

Purnima

Last Name

Garg

NPI

1639107816

Faculty ID

8920

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Languages

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p><strong>Education</strong></p>
<p>Medical School: Lady Hardinge Medical College, University of Delhi, New Delhi, India<br />Residency: Bronx-Lebanon Hospital Center (Family Medicine)</p>

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

4876

Is Open Scheduling

Off

Ruffaida Diwan

https://assets.montefioreeinstein.org/profiles/images/physphoto/Diwan_Ruffaida_MD_420x504.jpg

First Name

Ruffaida

Last Name

Diwan

NPI

1598058851

Faculty ID

13821

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

5306

Is Open Scheduling

Off

Nagma Dalvi

https://assets.montefioreeinstein.org/profiles/images/physphoto/Dalvi_Nagma_MD_420x504.jpg

First Name

Nagma

Last Name

Dalvi

NPI

1134474265

Faculty ID

16374

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

15287

Is Open Scheduling

Off